page actions

    page view

    References

    1. Royal College of Obstetricians and Gynaecologists: Obstetric Cholestasis, Guideline No.43. 2006
    2. EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. Journal of Hepatology 2009; 51: 237-267
    3. Pregnancy Intervention Trial in Cholestasis (PITCH): Pilot study for a trial of ursodeoxycholic acid (UDCA) and/or early delivery for obstetric cholestasis. 2008
    4. Kondrackiene, J. and Kupcinskas, L. Intrahepatic cholestasis of pregnancy-current achievements and unsolved problems. World J of Gastroenterol 2008; 4(38): 5781-5788
    5. Abedin, P. et al. Intrahepatic Cholestasis of Pregnancy: Prevalence and Ethnic Distribution. Ethn Health 1999; 4: 35-7
    6. Pusl, T. and Beuers, U. Intrahepatic Cholestasis of Pregnancy. Orphanet Journal of Rare Diseases 2007; 2:26
    7. Dixon, P H. and Williamson, C. The molecular genetics of intrahepatic cholestasis of pregnancy Obstet Med 2008 1: 65-71
    8. Geenes, V. and Williamson, C. Intrahepatic cholestasis of pregnancy World J Gastroenterol 2009 15: 2049-2066
    9. Kremer, A. et al. Lysophosphatidic acid is a potential mediator of cholestatic pruritus Gastroenterology 2010 [epub]
    10. Lammert, F. et al. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. Journal of Hepatology 2000; 33:1012-1021
    11. Hay, JE. Liver disease in pregnancy. Hepatology 2008; 47 (3): 1067-1076
    12. Joshi, D. et al. Liver disease in pregnancy. Lancet 2010; 375:594-605
    13. Kenyon, A. et al. Obstetric cholestasis, outcome with active management: a series of 70 cases. BJOG 2002; 109:282-288
    14. Glantz, A. et al. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing Dexamethasone and Ursodeoxycholic acid. Hepatology 2005; 42(6): 1399-1405
    15. Newnham J P. Jobe,  A H. Should we be prescribing repeated courses of antenatal corticosteroids?Semin Fetal Neonatal Med. 2009 Jun;14(3):157-63. Epub 2008 Dec 21.
    16. Williamson – Molecular action of new therapies for OC - BLT funded project
    17. BMA. British National Formulary 56, 2008.
    18. Glantz, A. Marscall, H. and Mattsson, L. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 2004; 40(2): 467-474
    19. Ropponen, A. et al. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases population-based study. Hepatology 2006; 43(4):723-728.
    20. Department of Health. Pregnancy & Alcohol. 2009
    21. Marschall HU et al. Clinical hepatotoxicity. Regulation and treatment with inducers of transport and cofactors. Molecular Pharmaceutics 2007; 4: 895-910.